SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., has released its financial results for the fourth quarter and full year 2023, which are consistent with its preliminary results announced on January 10, 2024. Fourth Quarter 2023 Highlights Revenue1 and Adjusted Revenue1,2 of $196.6 million Net loss of$25.9 million; Net loss margin of 13.2% Adjusted Net Income2 of $31.1 million; Adjusted Net ...